Identification of breast cancer associated variants that modulate transcription factor binding.
Identification of breast cancer associated variants that modulate transcription factor binding.
复制标题
DOI:
10.1371/journal.pgen.1006761
复制
发表时间:
2017-09
期刊:
影响因子:
4.5
通讯作者:
Guertin MJ
中科院分区:
文献类型:
--
作者:
Liu Y;Walavalkar NM;Dozmorov MG;Rich SS;Civelek M;Guertin MJ
Genome-wide association studies (GWAS) have discovered thousands loci associated with disease risk and quantitative traits, yet most of the variants responsible for risk remain uncharacterized. The majority of GWAS-identified loci are enriched for non-coding single-nucleotide polymorphisms (SNPs) and defining the molecular mechanism of risk is challenging. Many non-coding causal SNPs are hypothesized to alter transcription factor (TF) binding sites as the mechanism by which they affect organismal phenotypes. We employed an integrative genomics approach to identify candidate TF binding motifs that confer breast cancer-specific phenotypes identified by GWAS. We performed de novo motif analysis of regulatory elements, analyzed evolutionary conservation of identified motifs, and assayed TF footprinting data to identify sequence elements that recruit TFs and maintain chromatin landscape in breast cancer-relevant tissue and cell lines. We identified candidate causal SNPs that are predicted to alter TF binding within breast cancer-relevant regulatory regions that are in strong linkage disequilibrium with significantly associated GWAS SNPs. We confirm that the TFs bind with predicted allele-specific preferences using CTCF ChIP-seq data. We used The Cancer Genome Atlas breast cancer patient data to identify ANKLE1 and ZNF404 as the target genes of candidate TF binding site SNPs in the 19p13.11 and 19q13.31 GWAS-identified loci. These SNPs are associated with the expression of ZNF404 and ANKLE1 in breast tissue. This integrative analysis pipeline is a general framework to identify candidate causal variants within regulatory regions and TF binding sites that confer phenotypic variation and disease risk. The promise of effective personalized medicine is dependent upon the ability to identify genetic variants in the population that influence disease risk and then use this information to accurately predict the likelihood of disease incidence for individual patients. High-risk individuals may be entered into clinical trails, pre-clinical intervention strategies, or increased frequency of screening to detect early disease onset. However, the contribution of any one genetic variant to increase disease susceptibility is typically small, with many potential causal variants in the genomic region associated with risk. Therefore, it is important to understand the biological mechanisms by which the variants within a genetic region influence disease susceptibility by refining the set of all variants to those that are highly plausible to be causal. Herein, we describe a method to integrate molecular genomics data with genetic epidemiological data to inform on the underlying molecular mechanisms that influence breast cancer risk. This approach identifies the important transcription factors that directly regulate gene expression to modulate disease susceptibility.
登录
查看更多内容
影响因子:
4
作者:
Brachner A;Braun J;Ghodgaonkar M;Castor D;Zlopasa L;Ehrlich V;Jiricny J;Gotzmann J;Knasmüller S;Foisner R
通讯作者:
Foisner R
影响因子:
30.8
作者:
Das, Sayantan;Forer, Lukas;Schoenherr, Sebastian;Sidore, Carlo;Locke, Adam E.;Kwong, Alan;Vrieze, Scott I.;Chew, Emily Y.;Levy, Shawn;McGue, Matt;Schlessinger, David;Stambolian, Dwight;Loh, Po-Ru;Iacono, William G.;Swaroop, Anand;Scott, Laura J.;Cucca, Francesco;Kronenberg, Florian;Boehnke, Michael;Abecasis, Goncalo R.;Fuchsberger, Christian
通讯作者:
Fuchsberger, Christian
影响因子:
18.4
作者:
Bhagwat AS;Vakoc CR
通讯作者:
Vakoc CR
影响因子:
30.8
作者:
Carroll, Jason S.;Meyer, Clifford A.;Brown, Myles
通讯作者:
Brown, Myles
影响因子:
10.5
作者:
Bruhn, L;Munnerlyn, A;Grosschedl, R
通讯作者:
Grosschedl, R